Tibet Duo Rui Pharmaceutical: Notice on the delay in responding to the Shenzhen Stock Exchange Annual Report Inquiry Letter
Tibet Duo Rui Pharmaceutical: Legal Opinion of Zhonglun on the 2023 Annual General Meeting of Shareholders of Tibet Dorui Pharmaceutical Co., Ltd.
Tibet Duo Rui Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Tibet Duo Rui Pharmaceutical: Progress announcement on the use of the company's idle own funds for cash management
Dorui Pharmaceuticals: An indicative announcement on the disclosure of the report for the first quarter of 2024
Dorui Pharmaceuticals: Announcement to amend the company\'s articles of association
Dorui Pharmaceuticals: 2023 Internal Control Self-Evaluation Report
Dorui Pharmaceuticals: Non-operating capital occupation and other related financial transactions table
Dorui Pharmaceuticals: An indicative announcement on the 2023 Annual Report and Summary Disclosure
Dorui Pharmaceuticals: Accounting Services Selection and Employment System
Dorui Pharmaceuticals: Notice on Convening the 2023 Annual General Meeting of Shareholders
Dorui Pharmaceuticals: Announcement on Relinquishing Priority Transfer Rights for Holding Subsidiaries and Increasing Capital and Related Transactions with Subsidiaries
Dorui Pharmaceuticals: Announcement on the controlling shareholder pledging part of the shares
Dorui Pharmaceutical: Announcement on the intention to sign a project investment agreement with the Yicheng Municipal People\'s Government
Dorui Pharmaceutical: Progress Notice on Using the Company's Idle Own Funds for Cash Management, Expiration, and Continued Cash Management
Dory Pharmaceuticals: Announcement on the progress of using the company\'s idle own funds for cash management
Dorui Pharmaceuticals: Announcement on foreign investment
Dorui Pharmaceuticals: Announcement on foreign investment
Dorui Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the Second Extraordinary General Meeting of Shareholders of Tibet Dorui Pharmaceutical Co., Ltd. in 2023
Dorui Pharmaceutical: Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders in 2023
No Data